From NAFLD to NASH to HCC

Type 2 diabetes contributes to biological processes driving the severity of NAFLD, the primary cause for development of chronic liver diseases. Diagnosis, prevention, and treatment of the development and progression of NAFLD and NASH are important issues. In this review, H. Kim et al…
Read More

NASH-NAFLD: impact of sexual dimorphism

In their review, P. Burra et al. summarise the last findings about the influence of sex on epidemiology, pathogenesis, progression in cirrhosis, indication for liver transplantation and alternative therapies, including life styles modification and pharmacological strategies.

Read More

Burden of NAFLD in Canada

M. G. Swain et al. (University of Calgary, Canada) used a Markov model to forecast the burden of disease of NAFLD and NASH among Canadians with NAFLD from 2019 to 2030. The model projected that the number of NAFLD cases would increase by 20% between 2019 and 2030. Increasing rates of obesity …
Read More